NASDAQ: AVXL
Anavex Life Sciences Corp Stock Ownership - Who owns Anavex Life Sciences?

Insider buying vs selling

Have Anavex Life Sciences Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AVXL insiders and whales buy or sell their stock.

AVXL Shareholders

What type of owners hold Anavex Life Sciences Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christopher U. Missling1.63%1,510,165$1.96MInsider
Athanasios Skarpelos1.41%1,306,458$1.70MInsider
George Kalkanis0.97%900,000$1.17MInsider
Harvey Lalach0.59%550,000$715.00kInsider
Cameron Durrant0.08%75,000$97.50kInsider
Steffen Thomas0.05%43,651$56.75kInsider
Sandra Boenisch0.05%42,963$55.85kInsider
Blkrok0.01%8,056$10.47kInstitution
Blackrock Inc0.01%8,055$10.47kInstitution
George F. Tidmarsh0.01%8,000$10.40kInsider

1 of 3

AVXL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVXL0.04%4.79%
ARMP0.01%99.99%Net Selling
OTLK0.01%96.28%Net BuyingNet Buying
NKTX0.08%49.63%Net Selling
FHTX0.08%15.34%

Anavex Life Sciences Stock Ownership FAQ

Who owns Anavex Life Sciences?

Anavex Life Sciences (NASDAQ: AVXL) is owned by 0.04% institutional shareholders, 4.79% Anavex Life Sciences insiders, and 95.17% retail investors. Christopher U. Missling is the largest individual Anavex Life Sciences shareholder, owning 1.51M shares representing 1.63% of the company. Christopher U. Missling's Anavex Life Sciences shares are currently valued at $1.96M.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.